Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
28.18
-1.45 (-4.88%)
Mar 31, 2025, 10:11 AM EDT - Market open

Kymera Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Revenue
47.0778.5946.8372.8334.03
Upgrade
Revenue Growth (YoY)
-40.11%67.84%-35.71%114.00%1059.99%
Upgrade
Cost of Revenue
240.25189.08164.25137.0262.11
Upgrade
Gross Profit
-193.18-110.49-117.42-64.19-28.07
Upgrade
Selling, General & Admin
63.5355.0443.8336.3518.23
Upgrade
Operating Expenses
63.5355.0443.8336.3518.23
Upgrade
Operating Income
-256.71-165.53-161.26-100.53-46.3
Upgrade
Interest Expense
-0.25-0.2-0.18-0.18-0.12
Upgrade
Interest & Investment Income
38.0318.766.620.490.83
Upgrade
EBT Excluding Unusual Items
-218.93-146.96-154.81-100.22-45.59
Upgrade
Asset Writedown
-4.93----
Upgrade
Pretax Income
-223.86-146.96-154.81-100.22-45.59
Upgrade
Net Income
-223.86-146.96-154.81-100.22-45.59
Upgrade
Preferred Dividends & Other Adjustments
----9.05
Upgrade
Net Income to Common
-223.86-146.96-154.81-100.22-54.64
Upgrade
Shares Outstanding (Basic)
7558544817
Upgrade
Shares Outstanding (Diluted)
7558544817
Upgrade
Shares Change (YoY)
28.58%8.22%12.39%176.60%921.45%
Upgrade
EPS (Basic)
-2.98-2.52-2.87-2.09-3.15
Upgrade
EPS (Diluted)
-2.98-2.52-2.87-2.09-3.15
Upgrade
Free Cash Flow
-207.34-137.31-155.92-130.5479.03
Upgrade
Free Cash Flow Per Share
-2.76-2.35-2.89-2.724.55
Upgrade
Gross Margin
--140.59%-250.76%-88.13%-82.48%
Upgrade
Operating Margin
-545.36%-210.62%-344.37%-138.03%-136.05%
Upgrade
Profit Margin
-475.56%-186.99%-330.60%-137.60%-160.55%
Upgrade
Free Cash Flow Margin
-440.47%-174.71%-332.98%-179.24%232.22%
Upgrade
EBITDA
-250.74-163.47-159.48-99.03-45.24
Upgrade
EBITDA Margin
--207.99%--135.97%-132.93%
Upgrade
D&A For EBITDA
5.972.071.781.51.06
Upgrade
EBIT
-256.71-165.53-161.26-100.53-46.3
Upgrade
EBIT Margin
--210.62%--138.03%-136.05%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q